A detailed history of Clearline Capital LP transactions in Lensar, Inc. stock. As of the latest transaction made, Clearline Capital LP holds 173,004 shares of LNSR stock, worth $1.33 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
173,004
Previous 173,004 -0.0%
Holding current value
$1.33 Million
Previous $778,000 1.8%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$2.01 - $3.51 $114,551 - $200,038
56,991 Added 49.12%
173,004 $607,000
Q2 2023

Aug 14, 2023

BUY
$2.3 - $4.34 $145,044 - $273,693
63,063 Added 119.1%
116,013 $493,000
Q4 2021

Feb 14, 2022

BUY
$5.9 - $7.84 $312,405 - $415,128
52,950 New
52,950 $317,000

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $84.9M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.